Back to 
Brown Advisory Inc.
Brown Advisory Inc.
STLN
Showing 0 of 5 quarters
Position history for Brown Advisory Inc.'s holdings in Starling Oncology, Inc.
No. Brown Advisory exited its STLN (Starling Oncology) position in Q2 2024. Its Q1 2024 13F listed 18,674 shares worth $29,505. Brown Advisory first reported STLN in Q2 2023 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.